Form 8-K - Current report:
SEC Accession No. 0001104659-22-123853
Filing Date
2022-12-02
Accepted
2022-12-02 06:02:15
Documents
13
Period of Report
2022-12-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2231791d1_8k.htm   iXBRL 8-K 24772
2 EXHIBIT 99.1 tm2231791d1_ex99-1.htm EX-99.1 30863
  Complete submission text file 0001104659-22-123853.txt   236198

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rigl-20221201.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rigl-20221201_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rigl-20221201_pre.xml EX-101.PRE 22589
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2231791d1_8k_htm.xml XML 3506
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 221440197
SIC: 2834 Pharmaceutical Preparations